NO20052925D0 - Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse - Google Patents

Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse

Info

Publication number
NO20052925D0
NO20052925D0 NO20052925A NO20052925A NO20052925D0 NO 20052925 D0 NO20052925 D0 NO 20052925D0 NO 20052925 A NO20052925 A NO 20052925A NO 20052925 A NO20052925 A NO 20052925A NO 20052925 D0 NO20052925 D0 NO 20052925D0
Authority
NO
Norway
Prior art keywords
water
soluble anionic
chlorophyll derivatives
bchls
tetracyclic
Prior art date
Application number
NO20052925A
Other languages
English (en)
Other versions
NO334978B1 (no
NO20052925L (no
Inventor
Avigdor Scherz
Hugo Scheer
Alexander Brandis
Yoram Salomom
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30011928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20052925(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20052925D0 publication Critical patent/NO20052925D0/no
Publication of NO20052925L publication Critical patent/NO20052925L/no
Publication of NO334978B1 publication Critical patent/NO334978B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C07F15/0066—Palladium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06—Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO20052925A 2002-11-17 2005-06-15 Vannløselig anionisk bakterieklorofyllderivat, fremgangsmåte for fremstilling derav, farmasøytisk sammensetning som inneholder nevnte derivat og anvendelse derav. NO334978B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15290002A IL152900A0 (en) 2002-11-17 2002-11-17 Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
PCT/IL2003/000973 WO2004045492A2 (en) 2002-11-17 2003-11-17 Water-soluble anionic bacteriochlorophyll derivatives and their uses

Publications (3)

Publication Number Publication Date
NO20052925D0 true NO20052925D0 (no) 2005-06-15
NO20052925L NO20052925L (no) 2005-06-15
NO334978B1 NO334978B1 (no) 2014-08-11

Family

ID=30011928

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20052925A NO334978B1 (no) 2002-11-17 2005-06-15 Vannløselig anionisk bakterieklorofyllderivat, fremgangsmåte for fremstilling derav, farmasøytisk sammensetning som inneholder nevnte derivat og anvendelse derav.
NO2018012C NO2018012I1 (no) 2002-11-17 2018-04-10 Padeliporfin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2018012C NO2018012I1 (no) 2002-11-17 2018-04-10 Padeliporfin

Country Status (23)

Country Link
US (6) US7947672B2 (no)
EP (2) EP1567147B1 (no)
JP (3) JP4922559B2 (no)
CN (2) CN1741801B (no)
AU (1) AU2003282354C1 (no)
BE (1) BE2018C018I2 (no)
BR (1) BRPI0316319B8 (no)
CA (1) CA2506296C (no)
CY (2) CY1115458T1 (no)
DK (1) DK1567147T3 (no)
ES (1) ES2489516T3 (no)
FR (1) FR18C0002I2 (no)
HU (1) HUS1800020I1 (no)
IL (2) IL152900A0 (no)
LU (1) LUC00073I2 (no)
MX (1) MXPA05005262A (no)
NL (1) NL300934I2 (no)
NO (2) NO334978B1 (no)
NZ (1) NZ540790A (no)
PL (1) PL216661B1 (no)
PT (1) PT1567147E (no)
RU (1) RU2353624C2 (no)
WO (1) WO2004045492A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CN1980661B (zh) 2004-06-07 2011-09-28 耶达研究及发展有限公司 阳离子细菌叶绿素衍生物及其用途
US9957293B2 (en) * 2006-08-23 2018-05-01 Yeda Research And Development Company Ltd. Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
MX2010009530A (es) 2008-02-27 2010-11-30 Yeda Res & Dev Conjugados de rgd-(bacterio) clorofila para terapia fotodinámica y formación de imágenes de tumores necróticos.
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
JP6005076B2 (ja) 2011-03-11 2016-10-12 ステバ マオル エスアー 限局的光線力学的治療法
KR101962991B1 (ko) 2011-08-23 2019-03-27 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 안질환 및 질병 치료용 박테리오 클로로필 광민감제
CN105358702B (zh) 2013-03-11 2020-12-29 Tookad Ip有限责任公司 细菌叶绿素a的生产方法
RU2682674C2 (ru) 2013-03-15 2019-03-20 Шерри Энн МАКФАРЛЭНД Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение
EP3442582A1 (en) * 2016-04-10 2019-02-20 Yeda Research and Development Co. Ltd Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
CN107987081B (zh) * 2016-10-26 2019-12-06 刘辉 一种二氢卟吩e6衍生物及其药学上可接受的盐、其制备方法和应用
CA3047893C (en) * 2016-12-22 2022-11-15 Daiichi Sankyo Company, Limited Spink2 peptide for preventing and/or treating age-related macular degeneration
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
EP3723785A1 (en) * 2017-12-17 2020-10-21 Yeda Research and Development Co. Ltd Cop9 signalosome (csn) complex modulators and uses thereof
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用
CN116033913A (zh) * 2020-07-29 2023-04-28 国立大学法人北陆先端科学技术大学院大学 癌症的治疗药或诊断药
CN115843960A (zh) * 2022-11-03 2023-03-28 中国农业科学院农产品加工研究所 一种提高叶绿素稳定性的方法
IL311461A (en) * 2024-03-13 2025-10-01 Impact Biotech Ltd Process for preparing bacteriophophorbid derivatives and their alkali metal salts

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512762A (en) 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
JPS63196586A (ja) * 1987-02-12 1988-08-15 Toyo Hatsuka Kogyo Kk バクテリオフエオホ−バイド誘導体
DE3853995T2 (de) 1987-04-17 1995-11-23 David H Dolphin Porphyrine, verfahren zu deren herstellung und verwendungen.
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
JP3191223B2 (ja) * 1991-10-04 2001-07-23 株式会社光ケミカル研究所 ポルフィリン誘導体とその用途
JPH08506566A (ja) * 1992-06-19 1996-07-16 ザ・ユニバーシティ・オブ・トリド ポルフィリン系イミンの製造方法及び使用方法
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) * 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
FR2712493B1 (fr) * 1993-11-16 1996-01-19 Centre Nat Rech Scient Utilisation de photosensibilisateurs dérivés du noyau phorbine pour la décontamination du sang infecté par des parasites et/ou des virus.
JPH09110872A (ja) 1995-10-23 1997-04-28 Eiken Chem Co Ltd ヨードポルフィリン誘導体
IL116126A0 (en) 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
GB9524553D0 (en) * 1995-11-30 1996-01-31 Britton Charles J Plastic lever lid tins
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
KR100463478B1 (ko) * 1996-10-01 2004-12-29 와이스 가부시키가이샤 이미노클로린아스파르트산 유도체
IL129929A0 (en) * 1996-12-17 2000-02-29 Du Pont Polymerization of ethylene with specific iron or cobalt complexes novel pyridinebis (imines) and novel complexes of pyridinebis(imines) with iron and cobalt
RU2144538C1 (ru) * 1998-01-22 2000-01-20 Закрытое акционерное общество "Вета" Способ получения водорастворимых хлоринов
PT1137411E (pt) * 1998-12-09 2007-02-28 Yeda Res & Dev Processo para inibir respostas ao etileno em plantas
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
JP4277159B2 (ja) 2000-06-02 2009-06-10 独立行政法人科学技術振興機構 新規なテトラピロリル置換ポルフィリン及びその製法
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
WO2002013820A1 (en) 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
DE60213996T2 (de) * 2001-06-01 2007-09-06 Ceramoptec Gmbh Wasserlösliche porphyrinderivate für die photodynamische therapie, ihre verwendung und herstellung
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

Also Published As

Publication number Publication date
AU2003282354B8 (en) 2009-05-14
US20200094069A1 (en) 2020-03-26
WO2004045492A3 (en) 2004-07-08
HK1081858A1 (en) 2006-05-26
BRPI0316319B8 (pt) 2021-05-25
CA2506296A1 (en) 2004-06-03
US8461142B2 (en) 2013-06-11
BR0316319A (pt) 2005-09-27
AU2003282354A1 (en) 2004-06-15
FR18C0002I2 (fr) 2020-03-13
PL376734A1 (pl) 2006-01-09
CN102002048A (zh) 2011-04-06
MXPA05005262A (es) 2005-07-25
AU2003282354B2 (en) 2009-04-23
WO2004045492A2 (en) 2004-06-03
JP5555659B2 (ja) 2014-07-23
NL300934I2 (nl) 2018-05-22
US20110117029A1 (en) 2011-05-19
US7947672B2 (en) 2011-05-24
PL216661B1 (pl) 2014-04-30
US20170143988A1 (en) 2017-05-25
EP2522349A1 (en) 2012-11-14
DK1567147T3 (da) 2014-08-11
CY2018012I2 (el) 2018-09-05
LUC00073I2 (en) 2018-06-20
EP1567147B1 (en) 2014-05-07
RU2353624C2 (ru) 2009-04-27
FR18C0002I1 (no) 2018-06-15
AU2003282354C1 (en) 2009-10-29
NO2018012I2 (no) 2018-04-10
CA2506296C (en) 2012-09-11
CN102002048B (zh) 2012-11-28
ES2489516T3 (es) 2014-09-02
JP5566945B2 (ja) 2014-08-06
BRPI0316319B1 (pt) 2017-06-27
EP1567147A4 (en) 2008-07-09
CY1115458T1 (el) 2017-01-04
PT1567147E (pt) 2014-08-25
US20130345417A1 (en) 2013-12-26
NZ540790A (en) 2009-12-24
IL168480A (en) 2015-01-29
JP2011162551A (ja) 2011-08-25
EP1567147A2 (en) 2005-08-31
CY2018012I1 (el) 2018-09-05
CN1741801B (zh) 2010-12-22
NO334978B1 (no) 2014-08-11
US20150238773A1 (en) 2015-08-27
JP4922559B2 (ja) 2012-04-25
NO2018012I1 (no) 2018-04-10
US20060142260A1 (en) 2006-06-29
RU2005118771A (ru) 2006-01-20
JP2011148822A (ja) 2011-08-04
NO20052925L (no) 2005-06-15
BE2018C018I2 (no) 2023-03-07
JP2006515836A (ja) 2006-06-08
CN1741801A (zh) 2006-03-01
HUS1800020I1 (hu) 2018-05-28
IL152900A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
NO20052925D0 (no) Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
DE60321825D1 (de) Maleinsäureamid polymerderivate und ihre biokonjugate
CY1110405T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
ATE325802T1 (de) Verfahren zur aktivierung von menschlichen, antigen-aktivierenden zellen, aktivierte menschliche, antigen-aktivierende zellen und anwendungen derselben
DK1181323T3 (da) Biomaterialer dannet med nukleofil additionsreaktion med konjugerede uimættede grupper
ATE312103T1 (de) Substituierte porphyrine und deren therapeutische verwendungen
FR13C0021I1 (no)
PT1017675E (pt) Derivados da camtotecina altamente lipofilos
CY1118194T1 (el) Κατιονikα παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων
NO20073039L (no) Kontrastmidler
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
NO20063135L (no) Farmasoytiske preparater og fremgangsmater for insulinbehandling
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
WO2003026563A3 (en) Conjugated anti-psychotic drugs and uses thereof
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
ATE317846T1 (de) Phosphoramidat-prodrugs
TR199902775T2 (xx) 20(S)-Kamptotesin glikokonjugeleri.
DE60035192D1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
PT1606233E (pt) Derivados de esteres lipidicos de nucleotidos
WO2005010148A3 (en) Marks as modifiers of the pten pathway and methods of use
EA200100311A1 (ru) Бифункциональные антитела и их применение для прицельной доставки противоопухолевых средств
ATE528392T1 (de) Neues protein und dessen dns

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: PADELIPORFIN; REG. NO/DATE: EU/1/17/1228 20171115

Spc suppl protection certif: 2018012

Filing date: 20180410

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: PADELIPORFIN; REG. NO/DATE: EU/1/17/1228 20171115

Spc suppl protection certif: 2018012

Filing date: 20180410

Extension date: 20281117

MK1K Patent expired